Taiwan FDA registration cdfd0d66c2456bdd3de9a3cba39f1f3f
Reapan adrenocorticotropin detection reagent
TW: 禮亞尚促腎上腺皮質刺激素檢測試劑
Taiwan·Risk Class 2·DIASORIN ITALIA S.P.A.·Registered Oct 22, 2012 – Oct 22, 2027ActiveRegistration details
- Analysis ID
- cdfd0d66c2456bdd3de9a3cba39f1f3f
- Customs Code
- DHA00602409809
Company information
- Manufacturer
- DIASORIN ITALIA S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- The quantitative detection of the concentration of adrenocorticostimulating hormone in human EDTA plasma (cryostorage) by chemical cold light immunoassay (CLIA) must be used with the Liashang analyzer.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1025 Adrenocorticotropic hormone testing system
- Import Information
- import
Dates and status
- Registration Date
- Oct 22, 2012
- Expiry Date
- Oct 22, 2027
About this record
Access comprehensive regulatory information for Reapan adrenocorticotropin detection reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number cdfd0d66c2456bdd3de9a3cba39f1f3f and manufactured by DIASORIN ITALIA S.P.A.. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices